| Chirogate International Inc. | Taiwan | Inquire | ||
|---|---|---|---|---|
![]() | www.chirogate.com | |||
![]() | +886 (3) 496-3808 | |||
![]() | +886 (3) 496-3800 | |||
![]() | annyeh@chirogate.com kirogate@ms63.hinet.net | |||
| Chemical manufacturer since 2000 | ||||
| chemBlink Standard supplier since 2010 | ||||
| Shanghai Yingrui Biopharm Co., Ltd. | China | Inquire | ||
|---|---|---|---|---|
![]() | www.shyrchem.com | |||
![]() | +86 (21) 3358-5366 3466-6753 +86 13311639313 | |||
![]() | +86 (21) 3497-9012 | |||
![]() | sales02@shyrchem.com | |||
![]() | QQ Chat | |||
![]() | Skype Chat | |||
| Chemical manufacturer since 2009 | ||||
| chemBlink Standard supplier since 2017 | ||||
| Tecoland Corporation | USA | Inquire | ||
|---|---|---|---|---|
![]() | www.tecoland.com | |||
![]() | +1 (732) 603-9577 | |||
![]() | +1 (732) 906-1522 | |||
![]() | info@tecoland.com | |||
| Chemical distributor since 2001 | ||||
| chemBlink Standard supplier since 2019 | ||||
| Santa Cruz Biotechnology, Inc. | USA | Inquire | ||
|---|---|---|---|---|
![]() | www.scbt.com | |||
![]() | +1 (831) 457-3800 | |||
![]() | +1 (831) 457-3801 | |||
![]() | scbt@scbt.com | |||
| Chemical manufacturer | ||||
| Cayman Chemical Company | USA | Inquire | ||
|---|---|---|---|---|
![]() | www.caymanchem.com | |||
![]() | +1 (734) 971-3335 | |||
![]() | +1 (734) 971-3640 | |||
![]() | sales@caymanchem.com | |||
| Chemical manufacturer | ||||
| Classification | API >> Hormone and endocrine-regulating drugs >> Prostaglandins |
|---|---|
| Name | Prostacyclin sodium salt |
| Synonyms | Sodium (5Z,13E,15S)-6,9a-epoxy-11a,15-dihydroxyprosta-5,13-dien-1-oate |
| Molecular Structure | ![]() |
| Molecular Formula | C20H31O5.Na |
| Molecular Weight | 374.45 |
| CAS Registry Number | 61849-14-7 |
| EC Number | 263-273-7 |
| Melting point | 168-170 °C |
|---|---|
| Hazard Symbols | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Risk Statements | R20/21/22 Details | ||||||||||||||||||||
| Safety Statements | S22;S26;S36 Details | ||||||||||||||||||||
| Hazard Classification | |||||||||||||||||||||
| |||||||||||||||||||||
| SDS | Available | ||||||||||||||||||||
| Market Analysis Reports |
| List of Reports Available for Prostacyclin sodium salt |